• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过敏性紫癜中的血栓调节蛋白、组织型纤溶酶原激活物和纤溶酶原激活物抑制剂-1

Thrombomodulin, tissue plasminogen activator and plasminogen activator inhibitor-1 in Henoch-Schönlein purpura.

作者信息

Besbas N, Erbay A, Saatçi U, Ozdemir S, Bakkaloglu A, Ozen S, Topaloglu R

机构信息

Department of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

出版信息

Clin Exp Rheumatol. 1998 Jan-Feb;16(1):95-8.

PMID:9543574
Abstract

OBJECTIVE

To evaluate the changes in the plasma levels of thrombomodulin (TM), tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PA1-1) as indices of endothelial injury/activation and fibrinolysis in childhood Henoch-Schönlein purpura (HSP).

METHODS

Twenty-six children with HSP aged between 4-15 years and 10 healthy controls were included in the study. Blood samples were taken from these patients at admission and 6-12 weeks after healing of skin rash and arthritis. Plasma levels of TM, t-PA and PAI-1 activities and t-PA and PAI-1 antigen (Ag) levels were measured.

RESULTS

The plasma levels of TM, t-PA Ag and PAI-1 Ag in patients during the acute phase were significantly different from the controls. The difference in TM between the acute phase and recovery in patients was also significant. The decrease in plasma levels of t-PA Ag and PAI-1 Ag in patients between the acute and recovery phases was not significant. t-PA activity was significantly higher in the acute phase than in the recovery phase.

CONCLUSION

We suggest that increased levels of TM, t-PA, and PAI-1 activity may reflect the presence of endothelial injury and/or activation and fibrinolytic activation in patients with HSP.

摘要

目的

评估血浆中血栓调节蛋白(TM)、组织型纤溶酶原激活物(t-PA)和纤溶酶原激活物抑制剂-1(PAI-1)水平的变化,以此作为儿童过敏性紫癜(HSP)内皮损伤/激活和纤溶的指标。

方法

本研究纳入了26例年龄在4至15岁之间的HSP患儿和10名健康对照者。在这些患者入院时以及皮疹和关节炎愈合后6至12周采集血样。检测血浆中TM、t-PA和PAI-1的活性以及t-PA和PAI-1抗原(Ag)水平。

结果

急性期患者血浆中TM、t-PA Ag和PAI-1 Ag水平与对照组有显著差异。患者急性期与恢复期的TM差异也很显著。患者急性期与恢复期之间血浆中t-PA Ag和PAI-1 Ag水平的降低不显著。急性期t-PA活性显著高于恢复期。

结论

我们认为TM、t-PA和PAI-1活性水平升高可能反映了HSP患者存在内皮损伤和/或激活以及纤溶激活。

相似文献

1
Thrombomodulin, tissue plasminogen activator and plasminogen activator inhibitor-1 in Henoch-Schönlein purpura.过敏性紫癜中的血栓调节蛋白、组织型纤溶酶原激活物和纤溶酶原激活物抑制剂-1
Clin Exp Rheumatol. 1998 Jan-Feb;16(1):95-8.
2
Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis.血液透析患者中纤溶酶原激活物抑制剂-1、组织纤溶酶原激活物和血栓调节蛋白的循环水平:生化相关性及作为冠状动脉狭窄独立预测指标的作用
J Am Soc Nephrol. 2001 Jun;12(6):1255-1263. doi: 10.1681/ASN.V1261255.
3
[Fluctuations of tissue-type plasminogen activator.plasminogen activator inhibitor-1 complex in patients with DIC].[弥散性血管内凝血患者组织型纤溶酶原激活物 - 纤溶酶原激活物抑制剂 -1复合物的波动情况]
Rinsho Byori. 1994 Jul;42(7):707-12.
4
[Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in children with ulcerative colitis].
Pol Merkur Lekarski. 2006 Mar;20(117):326-8.
5
Levels of fibrinolytic activators and inhibitors in plasma after severe trauma.严重创伤后血浆中纤溶激活剂和抑制剂的水平
Blood Coagul Fibrinolysis. 1994 Feb;5(1):43-9.
6
[Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].[闭塞性动脉粥样硬化症和糖尿病大血管病变患者的纤溶酶原激活剂(组织型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂)及其他纤溶参数]
Pol Merkur Lekarski. 2001 Nov;11(65):414-7.
7
Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.某些骨髓增殖性综合征中的纤溶酶原激活剂(组织型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂)及纤溶酶原激活剂抑制剂(PAI - 1和PAI - 2)
Med Sci Monit. 2000 Jul-Aug;6(4):684-91.
8
Endothelial cell activation in cutaneous vasculitis.皮肤血管炎中的内皮细胞活化
Clin Exp Dermatol. 1996 Jan;21(1):28-32.
9
Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics.1型纤溶酶原激活物抑制剂对缺血性心脏病患者组织型纤溶酶原激活物介导的纤维蛋白溶解的调节作用:利尿剂可能产生的不利影响。
Coron Artery Dis. 1994 Jul;5(7):617-23. doi: 10.1097/00019501-199407000-00010.
10
Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.努南综合征患者纤溶酶原激活物抑制剂-1(PAI-1)与组织纤溶酶原激活物(t-PA)活性失衡
J Pediatr Hematol Oncol. 2010 Oct;32(7):532-6. doi: 10.1097/MPH.0b013e3181e0d152.

引用本文的文献

1
Relationship between IgA vasculitis and prothrombotic risk factors: A prospective, case-control study.IgA血管炎与血栓形成风险因素之间的关系:一项前瞻性病例对照研究。
Arch Rheumatol. 2024 Dec 12;39(4):670-678. doi: 10.46497/ArchRheumatol.2024.10711. eCollection 2024 Dec.
2
Henoch-Schonlein purpura with high factor VIII levels and deep venous thrombosis: an association or coincidence?伴有高凝血因子VIII水平及深静脉血栓形成的过敏性紫癜:一种关联还是巧合?
Rheumatol Int. 2008 Jul;28(9):935-7. doi: 10.1007/s00296-008-0542-7. Epub 2008 Feb 19.
3
Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Behçet's disease.
Rheumatol Int. 2004 Mar;24(2):98-102. doi: 10.1007/s00296-003-0324-1. Epub 2003 May 15.